Finance beat

Earnings

The Earnings beat on Finance tracks 636 verified stories, with 2 clearing multi-source corroboration in the last 7 days at mean impact 7/10 — live SQLite counts, not editorial weighting.

50 stories

Beat pulse

Last 7 days · Earnings

→
2 stories
7 avg impact
50% positive
50% negative
vs prior 7 days -2 -2 stories vs prior 7 days

Impact 7.0/10 (+1.5 vs prior). Counts are stories in our record, not a market forecast.

Open the change report

Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.

  • 50% positive
  • 50% negative

Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.

Figures are computed live from our source-verified story record (as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and sentiment are derived.

Beat actors

Who drives Earnings

Entities appearing in at least two verified earnings stories on this desk — ranked by mention count, not editorial preference.

Neutral 5

Smith & Nephew and AAON Signal Long-Term Growth in Q4 Earnings Reports

Smith & Nephew and AAON both reported Q4 results that emphasize long-term margin expansion and revenue targets through 2026 and beyond. While AAON faced a mixed quarter with flat revenue growth, Smith & Nephew's multi-year guidance suggests a structural turnaround in its orthopaedics and wound care segments.

Verified by 2 sources
Neutral 6

Workday Earnings Resilience: A Potential Signal for the SaaS Market Bottom

Workday's Q4 results surpassed analyst expectations on both top and bottom lines, driven by a significant surge in AI-related contract value. Despite issuing conservative guidance for the upcoming quarter, the stock's stability suggests that the broader software-as-a-service (SaaS) sector may have reached a valuation floor.

Verified by 2 sources
Neutral 5

Calumet and 1stdibs Q4 Results Highlight Industrial Pivot and Luxury Resilience

Calumet, Inc. reported a Q4 revenue miss of $1.04 billion as it navigates a complex transition to a C-Corp structure and scales its Montana Renewables subsidiary. Meanwhile, 1stdibs.com continues to refine its luxury marketplace model, focusing on operational efficiency amidst a shifting high-end consumer landscape.

Verified by 2 sources
Neutral 5

Spanish Corporates Signal Resilience as Insur and Acciona Energía Post Growth

Spanish real estate developer Inmobiliaria Del Sur (Insur) and renewable energy leader Acciona Energía have reported year-on-year profit growth for the full year 2025. These results underscore a period of operational efficiency and strategic expansion despite broader macroeconomic headwinds in the Eurozone.

Verified by 2 sources
Neutral 5

Getty Images and Designer Brands Slump as Earnings Outlooks Sour

Shares of Getty Images and Designer Brands faced sharp selling pressure on February 27, 2026, following disappointing financial updates. Both companies are grappling with structural shifts in their respective industries, from AI-driven disruption in digital media to a cooling consumer environment in retail footwear.

Verified by 2 sources
Bullish 7

Dell Shares Surge 17.5% as AI Server Revenue Forecast Doubles by FY27

Dell Technologies shares reached a three-month high after the company issued a bullish forecast projecting its AI-optimized server revenue will more than double by fiscal year 2027. This 17.5% stock surge underscores the intensifying demand for high-performance computing infrastructure as enterprises transition from AI experimentation to full-scale deployment.

Verified by 2 sources

Source: marketscreener.com · livemint.com

Neutral 5

Healthcare Services Resilience: Acadia and Spok Signal Growth in 2025 Year-End

Acadia Healthcare and Spok Holdings have released their year-end 2025 financial results, highlighting a period of operational stabilization and strategic pivot. While Acadia continues to navigate regulatory headwinds through facility expansion, Spok remains focused on its high-margin software transition and shareholder returns.

Verified by 2 sources
Neutral 5

Globant Revises 2026 Guidance Amid Shifting Digital Transformation Demand

Globant (NYSE: GLOB) has issued updated earnings guidance for the first quarter and full fiscal year 2026, following a period of significant stock volatility. The update comes on the heels of a February 19 analyst downgrade that saw shares gap down, signaling a recalibration of growth expectations in the AI and blockchain consulting sectors.

Verified by 3 sources

Source: themarketsdaily.com · tickerreport.com

Neutral 5

CRA International and Collegium Pharma Signal Resilience in Q4 2025 Results

CRA International (CRAI) and Collegium Pharmaceutical (COLL) both reported strong Q4 2025 results, highlighting a robust environment for specialized consulting and chronic pain management. While CRAI benefited from record headcount and high utilization in antitrust and litigation, Collegium demonstrated the continued commercial durability of its Belbuca and Xtampza ER franchises.

Verified by 2 sources
Neutral 5

Q4 Earnings Analysis: ACADIA and Alkami Navigate Growth and Market Volatility

ACADIA Pharmaceuticals and Alkami Technology reported Q4 results that highlight divergent paths for mid-cap growth entities. While ACADIA focuses on the commercial scaling of its rare disease portfolio, Alkami is battling a significant stock correction despite beating revenue expectations.

Verified by 2 sources
Bearish 7

Coupang Swings to Surprise Q4 Loss as Record Data Breach Fallout Deepens

Coupang reported a surprise $26 million loss for the fourth quarter, missing analyst estimates as the company grapples with the aftermath of South Korea's largest-ever data breach. Despite an 11% rise in revenue, the e-commerce giant saw its first sequential decline in active users and faces intense regulatory scrutiny alongside a controversial $1.5 billion compensation plan.

Verified by 2 sources
Neutral 5

Warby Parker and Seer Q4 Earnings Highlight Divergent Growth Paths

Warby Parker and Seer, Inc. both reported Q4 2025 results on February 26, 2026, revealing contrasting strategies for growth in the retail and life sciences sectors. While Warby Parker is leveraging physical store expansion to drive vision care services, Seer is navigating the complex commercialization of its proteomics platform.

Verified by 2 sources
Neutral 5

Ginkgo Bioworks Surprises Markets with Significant $0.38 EPS Earnings Beat

Ginkgo Bioworks (NYSE: DNA) outperformed analyst expectations by $0.38 EPS in its latest quarterly report, signaling a potential shift in the company's financial trajectory. The results suggest that the synthetic biology leader's cost-cutting measures and platform scaling are beginning to deliver tangible bottom-line improvements.

Verified by 2 sources
Neutral 5

Airgain and Golar LNG Post Q4 Results Amid Strategic Infrastructure Shifts

Airgain (AIRG) and Golar LNG (GLNG) released quarterly earnings, highlighting divergent paths in the wireless technology and energy sectors. While Airgain is pivoting toward a strategic platform ramp with its 5G and Wi-Fi 7 solutions, Golar LNG continues to solidify its position as a top-tier player in the global liquefied natural gas market.

Verified by 2 sources

Source: tickerreport.com · themarketsdaily.com

Neutral 5

Florida Insurance Market Stabilizes as Inogen and American Integrity Post Gains

American Integrity Insurance Group and Inogen, Inc. both reported Q4 2025 results this week, signaling a period of operational stabilization and bottom-line growth. While American Integrity benefited from a hardening Florida property market, Inogen's results reflect ongoing efforts to optimize its portable oxygen concentrator portfolio and improve gross margins.

Verified by 2 sources
Neutral 8

Nvidia’s Record Earnings Meet 'AI Fan-Fic' Reality Check as Markets Wobble

Nvidia delivered record-breaking quarterly results that surpassed analyst expectations, yet Wall Street's lukewarm reaction suggests a growing gap between AI speculative narratives and institutional valuation models. The market's 'post-earnings dip' highlights a shift in investor sentiment from blind optimism to a demand for sustainable long-term ROI.

Verified by 5 sources

Source: kasu.org · ksmu.org

Neutral 5

VTEX and Cable One Earnings Highlight Divergent Digital Growth

Enterprise commerce platform VTEX and broadband provider Cable One both issued quarterly earnings reports, highlighting the robust demand for digital infrastructure and scalable retail technology. While VTEX continues its push into global enterprise commerce, Cable One remains focused on its high-margin 'broadband-first' strategy in rural American markets.

Verified by 2 sources
Bullish 7

AI-Native Ecosystems and Strategic Wins Drive Growth for PAR and MercadoLibre

PAR Technology and MercadoLibre reported robust Q4 2025 results, signaling a shift from individual product sales to integrated AI-native ecosystems. PAR's landmark Papa John's deal and MercadoLibre's doubling credit portfolio highlight a period of aggressive expansion and operational efficiency driven by automated intelligence.

Verified by 2 sources
Neutral 5

Crinetics (CRNX) Advances Toward Commercialization Amid Q4 2025 Earnings Wave

Crinetics Pharmaceuticals (CRNX) reported Q4 2025 results, highlighting critical progress in its endocrine pipeline and preparations for the commercial launch of paltusotine. Alongside results from MDxHealth and Baldwin, the earnings cluster reflects a strategic transition for mid-cap healthcare and service firms navigating the 2026 market landscape.

Verified by 3 sources
Neutral 5

Exodus Movement to Report 2025 Results as Self-Custody Demand Surges

Exodus Movement, Inc. (NYSE: EXOD) will release its fourth quarter and full-year 2025 financial results on March 11, 2026. The report is expected to highlight the company's growth as a leading self-custodial platform during a pivotal year for digital asset adoption.

Verified by 2 sources
Neutral 5

CoStar Group Outpaces Estimates with Robust FY 2026 Earnings Guidance

CoStar Group (NASDAQ: CSGP) has issued fiscal year 2026 guidance that significantly exceeds Wall Street expectations for both earnings and revenue. The company projects an EPS range of $1.22 to $1.33, signaling strong operational momentum and confidence in its real estate data ecosystem.

Verified by 2 sources
Neutral 5

OneStream and Seer Outperform Earnings Estimates in Growth Sector Push

OneStream (OS) and Seer (SEER) both reported quarterly earnings that exceeded analyst expectations, signaling robust demand in enterprise software and life sciences technology. OneStream notably beat EPS estimates by $0.07 on $163.7 million in revenue, while Seer outperformed by $0.03.

Verified by 2 sources
Bullish 7

Q4 2025 Earnings Intelligence: SaaS Pivots and Tariff Resilience Define Results

A massive wave of Q4 2025 earnings reports reveals a corporate landscape aggressively pivoting toward recurring revenue models while navigating significant tariff and inflationary headwinds. Key performers in FinTech, SaaS, and Defense are demonstrating strong operating leverage despite localized consumer softness.

Verified by 19 sources
Neutral 5

Integra LifeSciences Faces Market Pressure as Turnaround Timeline Extends

Integra LifeSciences (IART) shares faced downward pressure following its Q4 2025 earnings call, as management detailed an extended timeline for its Boston facility restart and the ongoing costs of its Quality Excellence Program. While the company provided its first full-year 2026 guidance, investor caution remains high regarding the path to normalized growth and product re-launches.

Verified by 2 sources
Neutral 5

Solaris Energy and Boston Beer Signal Strategic Pivots in Q4 Earnings

Solaris Energy Infrastructure and The Boston Beer Company reported Q4 2025 results, revealing a market defined by industrial infrastructure expansion and consumer portfolio rebalancing. Solaris is accelerating its transition into broader energy logistics, while Boston Beer focuses on stabilizing its 'beyond beer' segment amid shifting tastes.

Verified by 2 sources
Neutral 5

Sector Divergence: Q4 2025 Earnings Reveal Resilience in MedTech and Retail

A wave of Q4 2025 earnings reports from mid-cap leaders across healthcare, automotive, and retail sectors highlights a bifurcated recovery. While MedTech and high-end retail show margin expansion, the EV and industrial sectors continue to navigate significant production and scaling headwinds.

Verified by 7 sources
Neutral 5

Payoneer Leads Mid-Cap Earnings Surge as B2B Resilience Offsets Macro Volatility

Payoneer reported robust Q4 2025 results, driven by double-digit growth in B2B volume and strategic expansion into emerging markets. The broader mid-cap landscape shows a divergence between high-growth consumer brands like Celsius and R&D-heavy biotech firms navigating a complex regulatory environment.

Verified by 12 sources
Neutral 5

Zscaler and LeMaitre Surge on Robust Earnings and Upgraded 2026 Outlooks

Zscaler (ZS) and LeMaitre (LMAT) shares climbed significantly following quarterly reports that exceeded analyst expectations for both top-line growth and margin expansion. The dual rallies highlight a market preference for sector leaders with high pricing power and resilient demand in cybersecurity and specialized medical devices.

Verified by 2 sources
Neutral 5

Bentley Systems and Red Robin Surge on Robust Earnings and Strategic Execution

Shares of Bentley Systems (BSY) and Red Robin (RRGB) rallied significantly following the release of their latest financial results, signaling strength in both infrastructure software and the casual dining sector. Bentley's growth was fueled by record infrastructure demand, while Red Robin's turnaround efforts yielded better-than-expected margin expansion.

Verified by 2 sources

Source: markets.financialcontent.com · markets.financialcontent.com

Bullish 6

Datadog and Frontdoor Surge as AI Partnerships and Earnings Beats Drive Gains

Datadog and Frontdoor shares climbed sharply on Thursday, driven by a combination of robust quarterly earnings and strategic pivots toward AI-integrated services. While Frontdoor exceeded analyst expectations across key financial metrics, Datadog's recovery was bolstered by a new partnership with Sakana AI and a successful DASH 2026 conference.

Verified by 2 sources
Neutral 5

Earnings Momentum and Sector Strength Lift Teladoc, ServiceNow, and Enovis

Teladoc Health shares surged following its latest financial results, while ServiceNow and Enovis also posted significant gains amid positive market sentiment. The movements highlight a robust period for healthcare technology and enterprise software as companies demonstrate resilient growth and operational efficiency.

Verified by 3 sources
Neutral 5

Pharma Earnings Preview: ANI and Amneal Set for Q4 2025 Growth Reports

ANI Pharmaceuticals and Amneal Pharmaceuticals are preparing to report Q4 2025 results, with investors focusing on rare disease expansion and biosimilar adoption. The broader earnings window also features updates from Fulgent Genetics and Alpha Metallurgical, highlighting a diverse landscape of diagnostic shifts and commodity pricing.

Verified by 4 sources
Bearish 6

Hut 8 Pivots to AI with $7B Lease Despite Deep Q4 Losses

Hut 8 reported a substantial net loss in Q4, driven by digital asset impairments, while simultaneously securing a landmark $7 billion AI data center lease. The results underscore the company's aggressive transition from volatile Bitcoin mining to stable, high-margin high-performance computing infrastructure.

Verified by 2 sources
Neutral 5

Pharma Earnings: Wave Life Sciences and Collegium Report 2025 Results

Wave Life Sciences and Collegium Pharmaceutical released their full-year 2025 financial results, highlighting a pivotal year for RNA therapeutics and specialty pain management. While Wave focuses on clinical milestones for its RNA editing platform, Collegium is driving growth through its commercial ADHD and pain portfolios.

Verified by 2 sources
Neutral 5

Cars.com and Lindblad Expeditions Post 2025 Results Amid Consumer Shift

Cars.com and Lindblad Expeditions reported their full-year 2025 results on February 26, 2026, highlighting a year defined by digital transformation in the automotive sector and a robust recovery in high-end adventure travel. Both companies navigated a complex macroeconomic environment of fluctuating interest rates and evolving consumer preferences.

Verified by 3 sources
Neutral 5

Mixed Earnings for Trulieve and MannKind Signal Sector-Specific Volatility

Trulieve Cannabis and MannKind reported divergent fourth-quarter results, with Trulieve beating earnings expectations despite a revenue miss, while MannKind saw a significant revenue surge that failed to translate into an EPS beat. These results highlight the ongoing tension between top-line growth and operational profitability in the cannabis and biopharma sectors.

Verified by 2 sources

About Finance Earnings coverage

According to our own tracking database, this category has accumulated 636 earnings stories since coverage began. This page aggregates the latest earnings stories within our finance coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track quarterly results, guidance, estimates and surface the angles a domain expert would actually read.

Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the finance beat.

Stories only surface on this page once the classifier scores them at a minimum 35 percent relevance to the category. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong on this page — a wrong stat, a broken source link, a miscategorized story? Report a data issue.

SignalWhat it tells you
Verified by N sourcesConfidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated.
Impact score (1-10)Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on.
SentimentFive-tier classification (very bullish through very bearish) trained on labeled finance-specific corpora.
Time stampRecency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed.